N

NuVasive Inc
F:NK8

Watchlist Manager
NuVasive Inc
F:NK8
Watchlist
Price: 36.8 EUR Market Closed
Market Cap: 1.9B EUR

Operating Margin

7.8%
Current
Improving
by 0.5%
vs 3-y average of 7.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
7.8%
=
Operating Income
$82.6m
/
Revenue
$1.2B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
7.8%
=
Operating Income
€82.6m
/
Revenue
$1.2B

Peer Comparison

Country Company Market Cap Operating
Margin
US
NuVasive Inc
F:NK8
1.9B EUR
Loading...
US
Abbott Laboratories
NYSE:ABT
210.1B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.9B USD
Loading...
US
Stryker Corp
NYSE:SYK
137.6B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
134.9B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
125.8B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.3B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
49.7B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.6B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.3B USD
Loading...
No Stocks Found

Market Distribution

In line with most companies in the United States of America
Percentile
54th
Based on 14 112 companies
54th percentile
7.8%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

NuVasive Inc
Glance View

Market Cap
1.9B EUR
Industry
Health Care

In the ever-evolving world of healthcare innovation, NuVasive Inc. stands as a noteworthy beacon in the field of spinal surgery technology. Founded in 1997 and based in San Diego, California, the company has carved a niche for itself with its minimally invasive surgical procedures designed to transform spinal care. The cornerstone of its success lies in its proprietary Maximum Access Surgery (MAS) platform, which reduces operating time and recovery periods for patients undergoing spinal procedures. By integrating its cutting-edge surgical solutions with advanced neuromonitoring technology and a comprehensive suite of procedural systems, NuVasive aids surgeons in executing complex operations with precision and efficiency. This unique amalgamation of technology and medical expertise not only enhances surgical outcomes but also has cemented NuVasive’s reputation as a leader in less-invasive spinal surgery. Financially, NuVasive harnesses an effective business model that generates revenue through the sale of its specialized surgical equipment, including implants and biologics, as well as through service offerings like its intraoperative monitoring services. The company's revenue streams are largely driven by product sales directly to hospitals and surgical centers, where innovative tools and technologies are in high demand. As healthcare facilities increasingly seek advanced methods to improve patient outcomes and operating efficiencies, NuVasive finds itself at the forefront of this demand, continuously expanding its product portfolio and global reach. By investing heavily in research and development, the company ensures its products stay at the cutting edge of medical technology, providing not just immediate financial growth, but also a long-term strategic advantage in the global market for spinal surgery solutions.

NK8 Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
7.8%
=
Operating Income
$82.6m
/
Revenue
$1.2B
What is NuVasive Inc's current Operating Margin?

The current Operating Margin for NuVasive Inc is 7.8%, which is above its 3-year median of 7.3%.

How has Operating Margin changed over time?

Over the last 3 years, NuVasive Inc’s Operating Margin has increased from 6% to 7.8%. During this period, it reached a low of 4.6% on Mar 31, 2021 and a high of 10.2% on Jun 30, 2021.

Back to Top